What is Biktarvy’s “primary completion date”?
“Primary completion date” is a clinical-trial field used on trial records to indicate the date when the study’s main follow-up for the primary endpoint was completed. The exact “primary completion date” for Biktarvy depends on the specific clinical trial (e.g., the NCT identifier).
Which Biktarvy trial are you looking for?
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) has multiple pivotal and supporting studies, each with its own completion dates. To give the correct primary completion date, you need one of the following:
- the NCT number (ClinicalTrials.gov identifier), or
- the study name/title, or
- the trial phase (e.g., Phase 3) and indication (e.g., treatment-naive vs. virologically suppressed).
Can you share the NCT number (or link)?
If you paste the ClinicalTrials.gov link or the NCT number for the Biktarvy study you mean, I can pull the exact “primary completion date” from that record.
Why the date may differ across sources or views
Even for the same trial, different websites can show different date fields (e.g., primary completion vs. study completion vs. last update posted). The “primary completion date” specifically tracks completion of primary endpoint follow-up, not necessarily when the entire study ended.
Sources
No sources were provided in your message, and I don’t have a specific Biktarvy trial identifier to look up the correct “primary completion date” for.